Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2015011730) FORMULATION COMPRISING A HYPOLIPIDEMIC AGENT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2015/011730 International Application No.: PCT/IN2014/000489
Publication Date: 29.01.2015 International Filing Date: 24.07.2014
Chapter 2 Demand Filed: 20.01.2015
IPC:
A61K 9/20 (2006.01) ,A61K 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
CADILA HEALTHCARE LIMITED [IN/IN]; Zydus Tower, Satellite Cross Roads Ahmedabad 380015 Gujarat, IN
Inventors:
PATEL, Jitendre, D.; IN
DAVADRA, Prakash; IN
PATEL, Snehal; IN
SHEIKH, Shafiq; IN
Agent:
SUBRAMANIAM, Hariharan; Subramaniam & Associates Central Square, Suite-328 Plaza III, 20 Manoharlal Khurana Marg, Bara Hindu Rao (off Rani Jhansi Road) Delhi 100006, IN
Priority Data:
2470/MUM/201325.07.2013IN
Title (EN) FORMULATION COMPRISING A HYPOLIPIDEMIC AGENT
(FR) FORMULATION COMPRENANT UN AGENT HYPOLIPIDÉMIANT
Abstract:
(EN) The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7. formula (I)
(FR) La présente invention concerne une composition pharmaceutique stable d'un agent hypolipidémiant approprié. De préférence, la présente invention décrit de nouvelles formulations du composé de formule (I), ou des sels pharmaceutiquement acceptables de composés de formule (1). Plus particulièrement, la présente invention concerne la composition pharmaceutique stable de composés de formule (I), comprenant des composés de formule (I) ou ses sels pharmaceutiquement acceptables, le pH de la formulation étant maintenu au-dessus de 7. Formule (I)
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
UAa201512675CA2917923SG11201509798PKR1020160013150CN105407873IL242767
AR097067US20160136131EP3024446EA201690072MX2015016971JP2016523895
NZ714558AU2014294548ID2017/07206MYPI 2015002885PH1/2015/502802VN47832
BR112015031878US20170266158IN3415/MUMNP/2015MA38865